comparemela.com

Latest Breaking News On - Ocumension therapeutics - Page 4 : comparemela.com

Nicox : Termination of the liquidity contract with Kepler

Press Release Nicox : Termination of the liquidity contract with Kepler CheuvreuxJanuary 3, 2024 – release at 7:30 am CETSophia Antipolis, FranceNicox SA.

Provence alpes côd azurNew yorkUnited statesFrance generalEric yooKepler cheuvreuxYi chenGavin spencerSophia antipolisHead of corporate developmentHarrow incGarnier coHc wainwright coPress releaseEuronext growth parisOcumension therapeutics

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related .

United statesAmy phillipsJays dukerChristina tartagliaMarcia sellos mouraJay dukerProgram leadership onBetta pharmaceuticalsAmerican academy of ophthalmologyExchange commissionAmerican society of retina specialistsCompany board of directorsEyepoint pharmaceuticals incEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqGreen room communications

Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones

Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomProvence alpes côd azurIhre chancenMont blancAndreas segerrosIndiens wirtschaftSophia antipolisGavin spencerGarnier co eric yoo parisHarrow incNicox groupEdison investment research pooya hemami londonHead of corporate developmentPress releaseProvides first halfThird quarter

EyePoint Pharmaceuticals : EYPT Investor Presentation October 2023 -October 17, 2023 at 05:16 pm EDT

Investor Presentation October 2023 Forward-Looking Statements Various statements made in this presentation.

Exchange commissionBetta pharmaceuticalsForward looking statementsSecurities litigation reform actOcumension therapeuticsEquinox science

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJays dukerAmy phillipsIndiens wirtschaftChristina tartagliaIhre chancenGeorge elstonEyepoint pharmaceuticals nasdaqExchange commissionHarvard business schoolEyepoint pharmaceuticalsGuggenheim securitiesHead of corporate developmentHead of corporate development at enzyvant therapeuticsPiper jaffrayEyepoint pharmaceuticals inc

vimarsana © 2020. All Rights Reserved.